HEGGIE THERESA — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

HEGGIE THERESA has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.10M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-15BCRXBIOCRYST PHARMACEUTICALS INCA — Grant or award15.3K$0.00
2026-03-24BCRXBIOCRYST PHARMACEUTICALS INCS — Open-market sale49.9K$10.11$505K
2026-03-24BCRXBIOCRYST PHARMACEUTICALS INCM — Option exercise49.9K$6.30$315K
2025-08-13BCRXBIOCRYST PHARMACEUTICALS INCS — Open-market sale70.0K$8.51$596K
2025-08-13BCRXBIOCRYST PHARMACEUTICALS INCM — Option exercise40.0K$5.41$216K
2025-08-13BCRXBIOCRYST PHARMACEUTICALS INCM — Option exercise30.0K$2.91$87K

Companies — Last 90 Days

Frequently Asked Questions

Who is HEGGIE THERESA?

HEGGIE THERESA is a corporate insider — currently tracked as Director of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has HEGGIE THERESA submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has HEGGIE THERESA been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.10M) across all tracked filings.

Where can I see all of HEGGIE THERESA's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live HEGGIE THERESA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.